Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma

Clinical and Translational Oncology

Volumn 15, Issue 10, 2013, Pages 796-801

  Lu, H ^a   Wang, Y ^a   Huang, Y ^a   Shi, H ^a   Xue, Q ^a   Yang, S ^a   He, S ^a   Wang, H ^b  

^a NANTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

c Myb; Cyclin D1; Esophageal squamous cell carcinoma; Proliferation

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; KI 67 ANTIGEN; PROTEIN C MYB;

ADULT; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYB; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84885179350     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1009-1     Document Type: Article

References (16)

1. Rustgi AK (2006) Models of esophageal carcinogenesis. Semin Oncol 33:S57-S58
2. Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD et al (2007) The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev 21:2788-2803
3. Greig KT, de Graaf CA, Murphy JM, Carpinelli MR, Pang SH, Frampton J et al (2010) Critical roles for c-Myb in lymphoid priming and early B-cell development. Blood 115:2796-2805
4. Bhaskar PK, Mukherjee A, Mutsuddi M (2012) Dynamic pattern of expression of dlin52, a member of the Myb/MuvB complex, during Drosophila development. Gene Expr Patterns 12:77-84
5. Lieu YK, Reddy EP (2009) Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci USA 106:21689-21694
6. Grabher C, Payne EM, Johnston AB, Bolli N, Lechman E, Dick JE et al (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. Leukemia 25:506-514
7. Thorner AR, Parker JS, Hoadley KA, Perou CM (2010) Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. PLoS One 5:e13073
8. Lutwyche JK, Keough RA, Hunter J, Coles LS, Gonda TJ (2006) DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein. Biochem Biophys Res Commun 344:1300-1307
9. Hugo H, Cures A, Suraweera N, Drabsch Y, Purcell D, Mantamadiotis T et al (2006) Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers. Genes Chromosomes Cancer 45:1143-1154
10. Drabsch Y, Robert RG, Gonda TJ (2010) MYB suppresses differentiation and apoptosis of human breast cancer cells. Breast Cancer Res 12:R55
11. Lei W, Liu F, Ness SA (2005) Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1. Blood 105:3855-3861
12. Wang Y, Yang S, Ni Q et al (2012) Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J Cell Biochem 113:2729-2737
13. Wang Y, Fei M, Cheng C, Zhang D, Lu J, He S et al (2008) Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Cancer Biol Ther 7:460-467
14. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
15. Holmes RS, Vaughan TL (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17:2-9
16. 2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23:1291-1299